Back to McKinsey Chart of the Day

Clinical trials for rare cancers can struggle to find patients

Many oncological diseases have struggled to attract attention from drug developers. That’s changing. But clinical trials can struggle to find enough patients.

In many rare cancers, there are nearly as many clinical-trial slots as patients.
We strive to provide individuals with disabilities equal access to our website. If you would like information about this content we will be happy to work with you. Please email us at:

To read the article, see “Precision medicine in practice: Strategies for rare cancers,” May 13, 2021.